Questions
Frequently Asked Questions
General
What problem does New Era Medicine solve?
The project addresses the critical lack of access to modern oncology and nuclear medicine infrastructure in many countries, where patients face late diagnoses, limited treatment options, outdated equipment, or the need to travel abroad for life-saving care.
What is the core mission of the project?
The core mission is to make advanced cancer diagnostics and treatment accessible where it does not yet exist—by deploying modern, standardized oncology infrastructure in a predictable, transparent, and scalable way.
Which countries does the project start in?
The project begins in countries with the highest infrastructure gaps and unmet oncology needs, initially focusing on Eastern Europe and selected emerging markets where access to modern cancer care is limited.
Who is behind New Era Medicine?
The project is led by a team with deep experience in healthcare operations, medical technology deployment, and infrastructure development, supported by advisors and partners from the medical and technology sectors.
Why combine oncology infrastructure with Web3 transparency?
Web3 transparency ensures that funding, progress, and outcomes are verifiable rather than trust-based. By combining healthcare infrastructure with on-chain reporting and open documentation, the project allows participants to clearly see how funds are used and how real medical facilities move from planning to operation.
Medical
What medical technologies are used in New Era centers?
New Era centers are built around advanced nuclear medicine and radiotherapy technologies, including PET-CT for early and precise diagnostics, linear accelerators (LINAC) for external beam radiotherapy, stereotactic radiosurgery systems, and supporting oncology IT systems for planning, imaging, and treatment coordination. The focus is on clinically proven, globally standardized equipment rather than experimental solutions.
How does the PET-CT → treatment pathway work?
The pathway starts with PET-CT imaging, which enables early detection, accurate staging, and precise tumor localization. Based on these results, clinicians define a personalized treatment plan that may include radiotherapy, radiosurgery, or combined oncology protocols. PET-CT is also used later to evaluate treatment effectiveness and adjust therapy if needed, creating a closed diagnostic-to-treatment loop.
What makes New Era Medicine different from existing oncology clinics?
New Era Medicine combines standardized, modern oncology infrastructure with transparent execution. Instead of isolated clinics with uneven quality, it delivers repeatable center designs, verified medical equipment, and clear reporting on deployment and operations. This ensures consistent care quality while allowing external stakeholders to see real progress, not just promises.
How long does a typical diagnostic and treatment cycle take?
A PET-CT diagnostic scan is typically completed within a single day, with clinical interpretation shortly after. Treatment planning usually follows within days, depending on complexity, while radiotherapy or radiosurgery is delivered over a defined course ranging from a single session to several weeks. The exact timeline varies by diagnosis, but the model is designed to minimize delays between diagnosis and treatment start.
Tokenomics
What is the total supply of the NERA token?
The NERA token has a fixed, capped total supply defined at launch. The full supply parameters are published in the tokenomics documentation and are not subject to change.
How are tokens allocated between sale, treasury and liquidity?
The supply is pre-allocated across three main buckets: a portion reserved for the public sale, a portion held in the project treasury to support long-term infrastructure deployment and operations, and a portion allocated to liquidity to ensure stable and functional market trading. All allocations are predefined and transparently disclosed.
Can tokens be minted in the future?
No. NERA is strictly non-inflationary. The total supply of 10 billion tokens is final, and no additional tokens can ever be minted. The only supply-side change permitted is a potential buyback and burn of up to 10% of the total supply, executed by the treasury if excess liquidity exists, which would reduce — not increase — the circulating supply.
Presale
Is KYC required to participate?
Yes. KYC and geo-checks are applied where required by law and jurisdiction. During the presale, participants must pass identity verification and sanctions screening before contributing to a batch smart contract. This ensures compliance with AML, sanctions, and Travel Rule requirements, especially for contributions above regulatory thresholds (e.g., ~SGD 1,500 under Singapore Travel Rule standards).
When do participants receive their tokens?
Participants receive their NERA tokens at the Token Generation Event (TGE). Tokens are not unlocked gradually during the presale. Instead, all allocations recorded across the 20 monthly presale batches are delivered in full at TGE, which is scheduled after completion of the final (20th) batch—approximately 20 months after the start of the presale.
What happens after the last presale batch?
After the 20th presale batch, the project publishes the final Data Room release confirming cumulative progress and milestones. This triggers the TGE, where NERA becomes a freely transferable token and initial listings go live on DEX and selected CEX venues. Initial liquidity is seeded from the 15% Liquidity & Market Making reserve, with a professional market-maker mandate activated. The TGE reference price is set with a 10–20% premium to the last batch price, after which the market price is determined solely by supply and demand.
